Stock listing

Anges. Inc.

Selected listing: 779518 · LS · EUR · DE

Anges. Inc. (Lang & Schwarz: 779518), Health Technology. Latest release Aug 14, 2026: AnGes : Consolidated Financial Report for the Second Quarter 2026.

779518:LSEURDEUpdated September 26, 2026

Ticker: Lang & Schwarz: 779518
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Generic
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Anges. Inc.

AnGes : Consolidated Financial Report for the Second Quarter 2026

August 14, 2026

AnGes : Notice Regarding the Conduct of a Type B CMC Meeting for the HGF gene therapy product

May 14, 2026

AnGes : Financial Results Summary of 1st Quarter 2026

May 8, 2026

AnGes : Consolidated Financial Report for the First Quarter 2026

May 8, 2026

AnGes : COLLATEGENE® (HGF gene therapy product); Proprietary ＆ USAN Names

April 29, 2026

All Anges. Inc. news →

Research Anges. Inc.

Anges. Inc. company profile

View the public company page for Anges. Inc. on 6ix.

Anges. Inc. news

Read company news and market updates connected to Anges. Inc..

Anges. Inc. investor events

Find investor webinars, events, and replay context for Anges. Inc..